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Background: Epitope prediction using computational methods represents one of the most promising approaches
to vaccine development. Reduction of time, cost, and the availability of completely sequenced genomes are key
points and highly motivating regarding the use of reverse vaccinology. Parasites of genus Leishmania are widely
spread and they are the etiologic agents of leishmaniasis. Currently, there is no efficient vaccine against this
pathogen and the drug treatment is highly toxic. The lack of sufficiently large datasets of experimentally validated
parasites epitopes represents a serious limitation, especially for trypanomatids genomes. In this work we highlight
the predictive performances of several algorithms that were evaluated through the development of a MySQL
database built with the purpose of: a) evaluating individual algorithms prediction performances and their
combination for CD8+ T cell epitopes, B-cell epitopes and subcellular localization by means of AUC (Area Under
Curve) performance and a threshold dependent method that employs a confusion matrix; b) integrating data from
experimentally validated and in silico predicted epitopes; and c) integrating the subcellular localization predictions
and experimental data. NetCTL, NetMHC, BepiPred, BCPred12, and AAP12 algorithms were used for in silico epitope
prediction and WoLF PSORT, Sigcleave and TargetP for in silico subcellular localization prediction against
trypanosomatid genomes.
Results: A database-driven epitope prediction method was developed with built-in functions that were capable of:
a) removing experimental data redundancy; b) parsing algorithms predictions and storage experimental validated
and predict data; and c) evaluating algorithm performances. Results show that a better performance is achieved
when the combined prediction is considered. This is particularly true for B cell epitope predictors, where the
combined prediction of AAP12 and BCPred12 reached an AUC value of 0.77. For T CD8+ epitope predictors, the
combined prediction of NetCTL and NetMHC reached an AUC value of 0.64. Finally, regarding the subcellular
localization prediction, the best performance is achieved when the combined prediction of Sigcleave, TargetP and
WoLF PSORT is used.
Conclusions: Our study indicates that the combination of B cells epitope predictors is the best tool for predicting
epitopes on protozoan parasites proteins. Regarding subcellular localization, the best result was obtained when the
three algorithms predictions were combined. The developed pipeline is available upon request to authors.* Correspondence: jeronimo@cpqrr.fiocruz.br
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Reverse vaccinology uses the genome sequences of viral,
bacterial or parasitic pathogens of interest rather than
the cells as starting material for the identification of
novel antigens, whose activity should be subsequently
confirmed by experimental biology approaches [1]. In
general, the aim of this approach is the identification of
genes potentially encoding pathogenicity factors and
secreted or membrane-associated proteins. In this con-
text, specific algorithms suitable for the in silico identifi-
cation of novel surface-exposed and, thus, antibody
accessible proteins mediating a protective immune re-
sponse are used [2].
Pizza and co-workers in collaboration with The Insti-
tute for Genomic Research (TIGR) provided the first ex-
ample of a successful application of the reverse
vaccinology approach [3]. They described that in silico
identification of vaccine candidates against Neisseria
meningitides serogroup B, which is the major cause of
sepsis and meningitis in children and young adults,
could be effective, while conventional approaches to ob-
tain a vaccine had failed for decades.
New powerful genomic technologies have increased
the number of diseases that can be addressed by vaccin-
ation, and have reduced the time of discovery research
and vaccine development [1]. Nowadays, it costs US$
200–400 million to research, develop, manufacture and
launch a new vaccine on the global market [4]. With the
use of reverse vaccinology, time and cost spent on the
search of new vaccine targets are significantly reduced.
Immunoinformatics is an emerging application of bio-
informatics techniques that focuses on the structure,
function, and interactions of the molecules involved in
immunity. One of its main goals is the in silico predic-
tion of immunogenicity at epitope level. Recently devel-
oped in silico tools and databases can be used to
identify, characterize or predict antigen epitopes recog-
nized by T- and B-lymphocytes, cells that play significant
roles in infection and protective immunity [5].
Epitopes are the minimal essential units of information
derived from self and nonself proteins that stimulate
cellular (T-cell) and humoral (B-cell) immune responses.
T-cells recognize T-cell epitopes that are derived from
endogenous and exogenous proteins and presented in
the cleft of MHC class I or MHC class II molecules at
the surface of antigen presenting cells to the T-cell re-
ceptor. After the activation of CD8+ T cells or CD4+ T
cells, respectively, cellular events, such as citotoxicity
and cytokine secretion, will occur. B-cells also recognize
epitopes, but generally intact proteins. B-cell epitopes
can be linear, contiguous amino acids, or discontinuous
amino acids that are brought together in folded proteins.
After activation, B-cells differentiate into plasmocytes
and start secreting antibodies. B- and T-cell responsesare called humoral and cellular adaptive immune
responses, respectively, and they inform the immune
system that a bacteria, virus, or parasite is present [6].
The subcellular localization of the protein is also im-
portant to investigate, as immunogenic proteins have to
be in contact with T- and B-cells in order to elicit a pro-
tective immune response. In other words, correct sub-
cellular localization is of great significance to the
functional analysis of proteins [7]. Therefore, various
prediction methods have been developed to predict pro-
teins’ subcellular location in the recent decades [8]. Pre-
diction methods to identify the subcellular location of
proteins can be classified into two categories: one is
based on the recognition of protein N-terminal sorting
signals [9] and the other is based on amino acid com-
position [10]. The predictors then combine these fea-
tures with machine-learning techniques to decide which
is the most probable location [11,12].
A large variety of machine-learning techniques are
commonly used in bioinformatics, including artificial
neural networks (ANNs) [13], hidden Markov models
(HMMs) [14] and support vector machines (SVMs) [15].
ANNs and SVMs are ideally suited to recognize non-
linear patterns, which are believed to contribute to, for
instance, peptide-HLA-I interactions [16]. In an ANN,
information is trained and distributed into a computer
network with an input layer, hidden layers and an output
layer all connected in a given structure through weighted
connections [13]. Finally, HMMs are well suited to char-
acterized biological motifs with an inherent structural
composition, and have been used in the field of immun-
ology to predict peptide binding to major histocompati-
bility complex (MHC) class I molecules [17].
The use of database system has been constant in the
life of researchers and professionals in several fields.
Conceptually, a database should be able to provide an
easy access to experimental results and lexical surveys,
preventing redundancy and wasteful duplication of re-
search data. A well-designed database should also be
able to provide support to researchers, facilitating guided
searches for novel correlations in data. On the other
hand, a poorly designed database makes the data mining
process difficult and the new data integration infeasible
for regular users [18] and in this perspective, the
rebuilding and redesigning processes are frequent
[18,19].
The current challenge of modern biology is to unravel
and understand the complex system of biological
organization and to signal in all of its details at a mo-
lecular level. An essential part of this process goes
through bioinformatics, particularly the use of manage-
ment systems, and relational databases applied to bio-
logical data. Biological data reside in specialized
databases that represent different data interpretation
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Also, biological data present a particularity: they are
highly complex when compared with data from most of
other applications. Thus, definitions of such biological
data must be able to represent a complex substructure
of data as well as their relationships, and also ensure
that no information is lost during the biological data
modeling. The data model must be able to represent any
level of complexity in any data schema, relationship, or
schema substructure and not just in a hierarchical, bin-
ary, or tabular data format [21].
The main objective of this present work was to build a
database-driven epitope prediction method capable of
accurately predicting parasite B- and T-cell epitopes, as
well as subcellular localization of parasites proteins
(Figure 1). The interface language used was standard
SQL (Standard Query Language) and several built-in
functions were implemented, but are not limited to, the
following: a) parse algorithms predictions and storage ofFigure 1 The methodology flowchart used to develop this work. A - C
on the curated Immune Epitope Database and Analysis Resource (IEDB) an
epitopes, MHC-II epitopes and subcellular location of proteins. C - Parsers d
database to integrate the results. E - Analysis of the results in the framewo
Report Language; SQL, Structured Query Language.experimental validated and predicted data; and b) evalu-
ation of algorithm performances.
Results
MHC-I epitopes prediction
Several approaches that predict peptide binding to MHC
molecules have been published [22]. In this study we opt
for two currently available algorithms, NetCTL [22] and
NetMHC [23]. Our choice for these MHC class I epitope
prediction algorithms was made in terms of ISI citation
indexes and regarding their availability for download and
local machine implementation.
When possible, in order to establish the ideal settings
for protozoan epitope prediction, the algorithms para-
meters were scanned and evaluated in terms of AUC
values. In this framework, the NetCTL score threshold
parameter was ranged from 0.50 to 0.90. The NetCTL
and NetMHC algorithms outputs were parsed and the
data of 3,906 in silico predicted epitopes loaded intoonstruction of the experimentally tested epitopes database, obtained
d on Uniprot. B - Algorithms used to predict B-cell epitopes, MHC-I
eveloped to extract the results. D - Construction of the relational
rk of AUC and confusion error matrix. PERL, Practical and Extraction
Figure 2 Strategy employed to assess the predictors’ performance. The scale bar represents the sequence of a theoretical protein of 120
amino acids. Dark blue rectangles represent one single epitope or a consensus of overlapping epitopes that were experimentally validated
according to IEDB (Positive exp.); light blue rectangles represent one single non-immunogenic region or a consensus of overlapping
non-immunogenic regions that were experimentally validated according to IEDB (Negative exp.); red rectangles represent the predicted epitopes
from evaluated algorithms. For B cell prediction the predicted epitopes were considered true positive if they aligned with minimum coverage of
50% and 100% of identity with a Positive Exp. Region; for CD8+ T cell prediction the predicted epitopes were considered true positive if they
aligned with minimum coverage of 87% and 100% of identity with a Positive Exp. region (Prediction 1, Prediction 2, Prediction 3 and Prediction
11). For B cell prediction the predicted epitopes were considered false positive if they aligned with minimum coverage of 50% and 100% of
identity with a Negative Exp. Region; for CD8+ T cell prediction the predicted epitopes were considered false positive if they aligned with
minimum coverage of 87% and 100% of identity with a Negative Exp. region (Prediction 6, Prediction 7, Prediction 8 and Prediction 13).
Predictions were not considered during the analysis if they did not align with the parameters cited above (Prediction 4, Prediction 5, Prediction 9
and Prediction 10) or if they aligned with both Positive exp. and Negative exp. (Prediction 12).
Table 1 Algorithms performance evaluation for B cell
epitope prediction and CD8+ T cells epitope prediction
Algorithms AUC values
CD8+ T cells epitope prediction
NetCTL 0.66
NetMHC 0.60
NetCTL and NetMHC 0.64




AAP12 and BCPred12 0.77
AAP12 and BepiPred 0.49
BCPred12 and BepiPred 0.58
AAP12, BCPred12 and BepiPred 0.57
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formances, predicted epitopes [see Additional file 1 and
Additional file 2] were aligned against the consensus ex-
perimentally validated dataset for MHC class I epitopes.
Figure 2 presents an overview of the benchmark ap-
proach undertaken in this study (see Methods Section
for more details). In addition, we carried out a combined
performance analysis using the best score threshold
found for each methodology (Table 1).
The AUC performance measure obtained for NetCTL
was 0.66 (for a score threshold of 0.50) and for NetMHC
was 0.60 (score thresholds cannot be modified by the
user). On the other hand, the combined performance of
these algorithms produced an AUC value of 0.64
(Table 1, Figure 3).
B-cell epitopes prediction
Following the same rational described above for MHC I
algorithm selection, three currently available algorithms
were chosen, BepiPred [24], BCPred12 [25] and AAP12
[26]. When possible, in order to establish the ideal set-
tings for protozoan epitope prediction, the algorithms
parameters were scanned and then evaluated in terms of
AUC values. In this framework, the score thresholds par-
ameter ranged from 0.15 to 0.90 for BepiPred and from
0.50 to 0.90 for AAP12 and BCPred12.
Using the developed pipeline, the default algorithms
outputs were parsed and the data of 187,187 in silico
predicted epitopes [see Additional file 3, Additional file
4 and Additional file 5] loaded into the MySQL data-
base. In order to evaluate the algorithm performances,
predicted epitopes were aligned against the consensus
experimentally validated dataset for B cell epitopes. Fur-
thermore, we carried out a combined performance ana-
lysis using the best score threshold found for each
methodology (Table 1, Figure 4).The AUC performance measure obtained was: 0.53 for
BepiPred using a threshold of 0.40; 0.52 for AAP12 using
a threshold of 0.80; and 0.62 for BCPred12 using a
threshold of 0.90 (Table 1). Regarding the combined per-
formance analysis performed for these algorithms, the
following results were found: 0.77 for AAP12 and
BCPred12; 0.49 for AAP12 and BepiPred; 0.58 for
BCPred12 and BepiPred; and 0.57 for AAP12, BCPred12
and BepiPred.
Subcellular localization of proteins prediction
Regarding prediction of subcellular localization of pro-
teins, three currently available algorithms were selected,
WoLF PSORT [27], Sigcleave [28] and TargetP [11].
Using the developed pipeline, the default algorithms out-
puts were parsed and the data of 538 in silico predictions
loaded into the MySQL database. In order to evaluate
the algorithms performances, an experimental validated
Figure 3 ROC (Received Operating Characteristics) curve representing the performance of CD8+ T cells epitope predictors analyzed
(NetCTL and NetMHC), from protozoan proteins database, and their combination. In addition, the black and grey curves represent the
performance of the same algorithms for human proteins database (SYFPEITHI) extracted from NetCTL homepage (http://www.cbs.dtu.dk/suppl/
immunology/CTL-1.2/syf.data.fsa).
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localization was loaded in addition to in silico predic-
tions. Results show that WoLF PSORT was capable of
correctly predicting 27/44 (61.36%) secreted proteins,
Sigcleave, 30/44 (68.18%), and TargetP, 32/44 (72.73%),
showing that the proportion of correctly predicted bin-
ders (sensitivity) was similar between the three algo-
rithms (Table 2). Files containing predictions made by
each algorithm are available as Additional files [see for
WoLF PSORT, Additional file 6; for Sigcleave, Additional
file 7; for TargetP, Additional file 8].
The evaluation of the intersecting portion of predic-
tions made by the tested algorithms showed that, from
40 protozoan proteins with extracellular localization ex-
perimentally determined, 19 (~48%) were correctly pre-
dicted by all three algorithms (Figure 5).
Discussion
Despite of being a major public health problem in sev-
eral countries, the life-threatening diseases caused by
protozoan parasites represent a challenge in terms of
vaccine development and nowadays there is no efficient
vaccine against these parasites.
Epitope prediction by computational methods repre-
sents one of the most promising approaches to vaccinedevelopment, but there are several drawbacks in the
process regarding trypanosomatid genomes. In this con-
text, the lack of sufficiently large datasets of experimen-
tally validated protozoan epitopes represents a serious
limitation for validation of parasite in silico epitope
prediction.
Several prediction methods were developed, but none
of them had protozoan parasites data as training dataset
(for some of them, protozoan parasites proteins
represent only about 10% of the training dataset
[24,25,29-32]) and, consequently, these results can be
biased and should be treated with a grain of salt. The
general wisdom is that the performance of epitope pre-
diction methods critically depends on the dataset used
for training and also on protein compositional bias. In
addition, it is influenced by the evaluation criteria.
Regarding epitope prediction in parasite genomes, these
drawbacks are noteworthy considering that these organ-
isms have a genome content that reflects proteins with a
particular physicochemical profile and that are underre-
presented in training datasets.
For this reason, we do not try to rank various predic-
tion methods. Rather, we focus on the key concepts and
ideas in the field. Thus, we evaluated algorithm perfor-
mances focusing on parasites genomes. Comparison
Figure 4 ROC (Received Operating Characteristics) curve representing the performance of B cells epitope predictors analyzed (AAP12,
BCPred12 and BepiPred), from protozoan proteins database, and their combination.
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under a ROC curve) values, which represent the
probability that a randomly selected positive instance
will score higher than a randomly selected negative
instance [33].
Aiming at identifying a good set of tools for protozoan
parasites epitope prediction and subcellular localization
of proteins, we developed, in this work, a database ap-
proach in order to integrate and evaluate the combined
performances of some open source currently available
algorithms for MHC class I and B-cell epitope predic-
tion, as well as for subcellular localization using proto-
zoan parasites proteins and epitopes experimentally
identified.Table 2 Analyzed parameters for subcellular location of
proteins
Subcellular location of proteins
WoLF PSORT Sigcleave TargetP
Sensitivity 61.36% (27/44) 68.18% (30/44) 72.73% (32/44)
Specificity 93.38% (127/136) 76.47% (104/136) 79.41% (108/136)
PPV 74.29% (26/35) 48.39% (30/62) 53.33% (32/60)
NPV 88.11% (126/143) 88.14% (104/118) 90% (108/120)
Accuracy 85.39% (152/178) 74.44% (134/180) 77.78% (140/180)
Figure 5 Venn diagram showing the evaluation of the
intersecting portion of predictions made by the tested
algorithms for subcellular localization of proteins. The
evaluation considered just the proteins experimentally determined
as extracellular (n=40).
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was developed and implemented integrating experimen-
tal validated data together with the information related
to MHC I prediction (NetCTL and NetMHC algorithms)
and B-cells prediction (BepiPred, AAP12 and BCPred12
algorithms).
The main source of experimental data was “Immune
Epitope Database and Analysis Resource” (IEDB) (http://
www.immuneepitope.org/) [34], that currently repre-
sents the main source of linear and conformational epi-
topes data. Besides, IEDB uses a metric that takes into
account the number of references, number of positive
assays, and total number of assays for each epitope
which is crucial to extract an experimentally validated
epitope subset with a high level of confidence for the
benchmark.
Regarding MHC I prediction, our AUC results indicate
a little difference in the performances related with
NetCTL and NetMHC algorithms, 0.66 and 0.60 re-
spectively. If we consider that it is reported that the
MHC class I prediction methods have achieved an ac-
curacy that in many cases allows for AUC values in the
range 0.95-0.99 [22], both algorithms didn0t achieve the
expected performance. In fact, this is not the first time
that underperformance of prediction algorithms is
reported in literature. In a recent study, 167 9mer pep-
tides from Influenza A virus were predicted as potential
binders by NetMHC, and just 89 of them (53% of the
pool) were confirmed as real binders [35]. Furthermore,
the underrepresentation of protozoan proteins in the
training datasets in general and the compositional bias
certainly have a deep impact on epitope prediction
methods and also in the benchmark. In fact, to highlight
the different performances of tested algorithms in front
of different datasets and exclude the influence of ap-
proach undertaken, we evaluated the algorithm perfor-
mances under the same framework but with the human
proteins dataset available for download from NetCTL
website [36-38]. The results for both NetCTL and
NetMHC algorithms were considerably better than the
results obtained for protozoan dataset. The AUC value
for NetCTL was 0.80 and for NetMHC was 0.77
(Figure 3). In addition, our performance evaluation does
not include MHCII prediction since experimental data
was insufficiently represented (data not shown). In prac-
tice, the prediction of MHC-peptide binding is far from
perfect, but this fact does not preclude all the advances
made in the last years in the field [21].
Regarding B-cell epitope prediction, our AUC results
indicate a better performance for BCPred12 algorithms
when compared to AAP12 and BepiPred (Table 1).
Again the observed performances were inferior from
those currently observed for B-cell epitope predictions
[24]. This difference might be explained by same reasonswhich were just discussed for MHCI prediction. Also for
B-cell epitope prediction, this is not the first report in
literature of low epitope prediction performance [39].
Lafuente and Reche (2009) believe launching a Critical
Assesment of Techniques for Epitope Prediction will
benefit the field. Under this program, computational
methods will be used for blind de novo prediction of
peptides that are immunogenic from query proteins that,
for evaluation purposes, has been experimentally
screened [21]. Considering that and the results obtained
by us, we do believe this approach will be useful to bring
advances to epitope prediction area.
Despite of the shortcomings cited above, the combined
performance analysis seems to be a promising approach.
For B-cell algorithms, when the combined performance
analysis was made, the best combination performance
was found for AAP12 and BCPred12 that reached an
AUC value of 0.77, which is within the expect range
reported [24].
Seen in the light of the results obtained, the developed
approach calls attention to several points: a) The general
prediction models used by currently available algorithms
cannot be used with the same performance for different
protein subsets (especially true for protozoan parasites);
b) The need for studies in which the algorithm perfor-
mances are evaluated for underrepresented and compos-
itional biased proteins subsets; and c) The combinatorial
prediction approach can improve the epitope prediction
performance.
Concerning the subcellular localization prediction, the
database schema developed also integrated experimental
and predicted data for subcellular localization of pro-
teins. Experimental data was obtained from UniProt
(http://www.uniprot.org), and the in silico predictions
made by WoLF PSORT, Sigcleave and TargetP algo-
rithms. The result shows that there is not much differ-
ence, in terms of percentage of matches, between the
tested algorithms. Nevertheless, the Venn diagram ana-
lysis related to true positives (extracellular localization)
result shows that the tested algorithms match different
proteins in the dataset, and the consensus prediction of
the three algorithms would better define a protein
located in the extracellular compartment.
Conclusions
Considering the public health importance of the studied
organisms and the lack of studies specifically addressing
epitope and subcellular localization prediction in these
parasites, our results suggest that the algorithm com-
binatorial approach employed in the developed
database-driven epitope prediction methodology is cap-
able of proposing the best set of tools for in silico epi-
tope prediction in protozoan parasite genomes. Several
drawbacks exist, but the present work will certainly
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tion of potential candidates for vaccine development.
Methods
Databases of experimentally tested epitopes
Two datasets of experimentally tested epitopes were
built, one of B-cell epitopes and another of MHC-I epi-
topes. Parasite proteins experimental datasets where
extracted from Immune Epitope Database and Analysis
Resource (IEDB) [34,40,41]. The following criteria were
adopted for epitope selection: a) from protozoan para-
sites; b) host organism must be mice or human. Selected
epitopes were minimal epitopes, experimentally vali-
dated as immunogenic [see Additional file 9 and Add-
itional file 10, for B and T-cell epitopes, respectively] or
non-immunogenic [see Additional file 11 and Additional
file 12, for B and T-cell non-immunogenic regions,
respectively].
Furthermore, several overlapping epitopes anchored in
the same protein region were observed. In order to have
a non-redundant set of experimentally validated regions
for each protein from dataset, make sense for us to use
what we call “the consensus validated region”, which
consists to cluster the overlapping epitopes in a unique
consensus region called “experimentally validated con-
sensus region”.
Thus, the dataset of B-cell experimental epitopes
ended up with 312 proteins and 866 experimentally vali-
dated consensus regions including immunogenic and
non-immunogenic [see Additional file 13 and Additional
file 14, respectively]; for MHC-I epitopes, 81 proteins
and 224 experimentally validated consensus regions in-
cluding immunogenic and non-immunogenic assign-
ments [see Additional file 15 and Additional file 16,
respectively]. Furthermore, these data were used as input
for the formatdb program (BLAST package) which pre-
pares the sequences to be aligned as subject by the
BLAST algorithm [42].
Database of proteins with experimentally validated
subcellular localization
Proteins with experimentally validated subcellular
localization were obtained from UniProt. The search was
done with the term “trypanosomatidae”, with the field
“subcellular location” set to the confidence “experimen-
tal”, which retrieved 180 proteins with subcellular
localization described experimentally [see Additional file
17 and Additional file 18]. This dataset was used to
evaluate the three selected algorithms for subcellular
localization prediction.
Selection of prediction tools
The prediction algorithms were selected taking into ac-
count the possibility of being installed locally, and thereliability of their predictions reported on literature. The
predictions of the following algorithms were evaluated:
a) for MHCI epitope prediction: NetCTL [22,32,43] and
NetMHC [23,31,44]; b) for B-cell epitope prediction:
BepiPred [24] and BCPreds [25,26,29], which included
two methodologies, AAP12 and BCPred12; c) for protein
subcellular localization prediction, WoLF PSORT [27],
Sigcleave [28] and TargetP [11].
Score thresholds and allele used
Score thresholds used for CD8+ T cell epitope predictors
ranged from 0.50 to 0.90 for NetCTL. We did not set
the threshold value for NetMHC because this parameter
is not variable in the NetMHC command line mode, so
a unique value (0.426) was used for NetMHC. Concern-
ing B cell epitope predictors, the score thresholds ranged
from 0.50 to 0.90 for AAP12 and BCPred12 and from
0.15 to 0.90 for BepiPred.
For CD8+ T cell epitopes prediction, the human super-
type A2 was the allele model used to scan MHC binding
affinity. Other HLA alleles are present in IEDB, but
regarding the protozoan proteins they are underrepre-
sented in the non-redundant database used (see previous
section). In addition, the supertype HLA-A2 is included
in a group which is expressed in 88% of the population,
what illustrates the relevance of the supertype used in
this work.
Development of parsers and algorithms
Parsers and algorithms were developed in PERL and
SQL languages in order to extract the results obtained
after running the programs and help to integrate all the
results in the relational database.
Construction of relational database
To aggregate all information generated during the devel-
opment of the project we used MySQL as a Relational
Database Management System (RDBMS) (http://www.
mysql.com). The use of a database system in this work
represents a manner of getting a data receptacle or con-
ceptual repository from which was possible to extract
data correlation and results. The MySQL GUI Tools
(http://dev.mysql.com/downloads/gui-tools/5.0.html) were
used as a graphical user interface for our MySQL data-
base. The entity-relational model (ERM) was built using
MySQL Workbench (http://wb.mysql.com). For automatic
data parsing and to load information into database, Perl
scripts using DBI and BioPerl modules were developed.
An overview of implemented workflow is presented in
Figure 1.
Analysis of the epitopes results
The developed methodology for result analyses was
based on threshold dependent parameters and also on
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the regions of the source proteins which were assigned
as consensus experimentally validated regions (im-
munogenic or non-immunogenic), and with the results
of the predictions made by the tested algorithms
stored on the constructed relational database, we iden-
tified the True Positives (TP) and False Positives (FP)
hits. This information was employed in the AUC per-
formance analysis.
In our methodology, we classified the predicted epi-
topes as TP or FP using the results produced from
BLAST algorithm [42]. The following parameters were
utilized to decide if a prediction was going to be consid-
ered as TP: 1) the local alignment between an epitope
prediction (query) and an immunogenic consensus ex-
perimentally validated region (subject) had to have min-
imal query coverage (50% for B cell prediction and 87%
for CD8+ T cell). In addition, the coverage cutoff was
established based on a minimum size of B cell and CD8
+ T cell found in the experimental epitopes database
used (IEDB) which are 6 and 8 amino acids respectively.
The NetCTL and NetMHC algorithms predict epitopes
with 9 amino acids, thus 87% of coverage guarantees the
minimum epitope alignment size of 8 amino acids. By
the other hand, the AAP12 and BCPred12 algorithms
predict epitopes with 12 amino acids, therefore 50% of
coverage guarantees the minimum epitope alignment
size of 6 amino acids. Regarding the BepiPred algorithm,
since it predicts epitopes with variable sizes, only those
with at least 6 amino acids were considered in the ana-
lysis. Specifically for predictions ranging from 6 to 11
amino acids, the coverage cutoff varied to guarantee a
minimal amino acid alignment length of 6 residues. 2)
The local alignment between an epitope prediction and
a consensus experimentally validated region (immuno-
genic) had to have 100% of identity. This parameter was
used to confirm that a given subject extracted from an
alignment exactly matches with the real query. 3) Finally,
in order to guarantee subject and query reciprocity the
query name and the subject name must be the same.
Using the same rational a prediction was considered FP,
but the alignment analyses were made using as subjectTable 3 Parameters used in the analysis of the results
Parameter Brief description
Sensitivity (Sn) The proportion of correctly predicte
Specificity (Sp) The proportion of correctly predicte
Positive Predictive Value (PPV) The probability that a predicted bin
Negative Predictive Value (NPV) The probability that a predicted non
Accuracy The proportion of correctly predicte
a = True positive observations.
b = False positive observations.
c = False negative observations.
d = True negative observations.the non-immunogenic consensus experimentally vali-
dated region. Predicted epitopes that did not align with
the parameters cited just above or if they aligned with
both immunogenic and non-immunogenic consensus
experimentally validated region were not considered for
further analysis.Algorithms combined predictions
To perform the combined prediction we adopted the fol-
lowing rational: 1) for a given protein, the experimental
regions are indexed and so, considering a protein (P)
with three experimental validated regions, they would be
named P1, P2 and P3; 2) if a given algorithm A predicts
an epitope that matches with P2 for instance and an-
other algorithm B predicts an epitope that also matches
with P2 they are considered a combined prediction; 3) if
a given algorithm A predicts an epitope that matches
with P2 and another algorithm B predicts an epitope
that matches with P1 or P3 they are not considered as a
combined prediction.
Based on the above rules, the combined prediction
score was calculated as the mean of the individual nor-
malized scores of the original predictions. The score
normalization was done as follows:
NS=(PS-MLS)/((MHS-MLS)/100), where:
NS = normalized score;
PS = prediction score;
MLS = methodology lowest score;
MHS = methodology highest score.Accuracy evaluation
A non-parametric performance measure was used to
avoid the influence of arbitrary thresholds. In order to
carry out an accuracy evaluation, we used the area under
the ROC curve, or simply AUC, that aggregates the
model’s behavior for all possible decision thresholds.
The nonparametric estimate of the AUC [45] was calcu-
lated through an implemented GNU R package called
ROCR [33].Formula
d binders (a/(a + c))*100
d non-binders (d/(b + d))*100
der will actually be a binder (a/(a + b))*100
-binder will actually be a non-binder (d/(c + d))*100
d peptides (both binders and non-binders) ((a + d)/(a+b+c+d)*100
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In order to analyze the subcellular localization predic-
tion results, we determined the True Positives (TP), True
Negatives (TN), False Positives (FP) and False Negatives
(FN). This information was incorporated into a confus-
ing error matrix that allowed the determination of
parameters: sensitivity (Sn), specificity (Sp), positive pre-
dictive value (PPV), negative predictive value (NPV) and
accuracy (Table 3).Additional files
Additional file 1: Epitopes predicted by NetCTL. This file in fasta
format contains 2,657 epitopes predicted by NetCTL.
Additional file 2: Epitopes predicted by NetMHC. This file in fasta
format contains 1,249 epitopes predicted by NetCTL.
Additional file 3: Epitopes predicted by BepiPred. This file in fasta
format contains 5,450 epitopes predicted by BepiPred.
Additional file 4: Epitopes predicted by AAP12. This file in fasta
format contains 138,987 epitopes predicted by AAP12.
Additional file 5: Epitopes predicted by BCPred12. This file in fasta
format contains 42,750 epitopes predicted by BCPred12.
Additional file 6: Predictions made by WoLF PSORT. This file
contains predictions made by WoLF PSORT.
Additional file 7: Predictions made by Predictions made by
Sigcleave. This file contains predictions made by Sigcleave.
Additional file 8: Predictions made by TargetP. This file contains
predictions made by TargetP.
Additional file 9: B-cell minimal epitopes experimentally validated
extracted from IEDB. This file in fasta format contains 3,021 B-cell
minimal epitopes from parasite proteins experimentally validated as
immunogenic extracted from IEDB.
Additional file 10: CD8+ T cell minimal epitopes experimentally
validated extracted from IEDB. This file in fasta format contains 228
CD8+ T cell minimal epitopes from parasite proteins experimentally
validated as immunogenic extracted from IEDB.
Additional file 11: B-cell non-immunogenic regions experimentally
validated extracted from IEDB. This file in fasta format contains 3,039
B-cell non-immunogenic regions from parasite proteins experimentally
validated extracted from IEDB.
Additional file 12: CD8+ T cell non-immunogenic regions
experimentally validated extracted from IEDB. This file in fasta format
contains 166 CD8+ T cell non-immunogenic regions from parasite
proteins experimentally validated extracted from IEDB.
Additional file 13: B-cell immunogenic consensus regions
experimentally validated. This file in fasta format contains 607 B-cell
immunogenic consensus regions from parasite proteins experimentally
validated.
Additional file 14: B-cell non-immunogenic consensus regions
experimentally validated. This file in fasta format contains 243 B-cell
non-immunogenic consensus regions from parasite proteins
experimentally validated.
Additional file 15: CD8+ T cell immunogenic consensus regions
experimentally validated. This file in fasta format contains 140 CD8+ T
cell immunogenic consensus regions from parasite proteins
experimentally validated.
Additional file 16: CD8+ T cell non-immunogenic consensus
regions experimentally validated. This file in fasta format contains 84
CD8+ T cell cell non-immunogenic consensus regions from parasite
proteins experimentally validated.Additional file 17: Trypanosomatid proteins with experimentally
validated subcellular localization extracted from Unitprot. This file
contains a list of 180 trypanosomatid proteins with its subcellular
localization experimentally validated extracted from Uniprot.
Additional file 18: Trypanosomatid proteins in fasta format with
experimentally validated subcellular localization. This file in fasta
format contains 180 trypanosomatid proteins with its subcellular
localization experimentally validated.
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